scholarly article | Q13442814 |
P356 | DOI | 10.3109/1547691X.2014.880533 |
P698 | PubMed publication ID | 24512329 |
P50 | author | Benjamin Frey | Q38326649 |
Niels Schaft | Q43193257 | ||
Jan Dörrie | Q46174669 | ||
Lisa Deloch | Q59817017 | ||
Rainer Fietkau | Q64584867 | ||
P2093 | author name string | Udo S Gaipl | |
Yvonne Rubner | |||
Lorenz Kulzer | |||
Andrea Allgäuer | |||
P2860 | cites work | Combining radiotherapy and cancer immunotherapy: a paradigm shift | Q27021428 |
Dendritic cells and the control of immunity | Q27860918 | ||
The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity | Q28304923 | ||
Anti-tumor immunity: myeloid leukocytes control the immune landscape | Q28390573 | ||
Dendritic cells: specialized and regulated antigen processing machines | Q29617085 | ||
Functional diversity of helper T lymphocytes | Q29619415 | ||
Immunologic correlates of the abscopal effect in a patient with melanoma | Q29620334 | ||
Transforming growth factor-beta activation in irradiated murine mammary gland | Q34128453 | ||
Cytokine patterns in patients with cancer: a systematic review. | Q34342581 | ||
A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy | Q34949098 | ||
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy | Q35540109 | ||
Cytometric bead array: a multiplexed assay platform with applications in various areas of biology | Q35718665 | ||
Radiation-induced cell death and dendritic cells: potential for cancer immunotherapy? | Q36044123 | ||
Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment | Q37268974 | ||
CD25 as an immune regulatory molecule expressed on myeloid dendritic cells | Q37300261 | ||
In vitro assays of allosensitization | Q37328591 | ||
Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody | Q37351567 | ||
Systemic effects of local radiotherapy | Q37539309 | ||
Harnessing dendritic cells in cancer | Q37835970 | ||
Radiobiological rationale and clinical implications of hypofractionated radiation therapy. | Q37868153 | ||
How does ionizing irradiation contribute to the induction of anti-tumor immunity? | Q38030920 | ||
American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) practice guideline for the performance of total body irradiation (TBI). | Q38075441 | ||
Tumor-altered dendritic cell function: implications for anti-tumor immunity | Q38123166 | ||
Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation. | Q40144504 | ||
A new way to generate cytolytic tumor-specific T cells: electroporation of RNA coding for a T cell receptor into T lymphocytes | Q40340738 | ||
Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor | Q40412166 | ||
Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes | Q40497215 | ||
Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation. | Q50777089 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | adaptive radiation therapy | Q180507 |
dendritic cell | Q506253 | ||
P304 | page(s) | 328-336 | |
P577 | publication date | 2014-02-10 | |
P1433 | published in | Journal of Immunotoxicology | Q6295320 |
P1476 | title | Norm- and hypo-fractionated radiotherapy is capable of activating human dendritic cells | |
P478 | volume | 11 |
Q58701245 | Alterations of MicroRNA Expression in the Liver, Heart, and Testis of Mice Upon Exposure to Repeated Low-Dose Radiation |
Q39203685 | Barriers to Radiation-Induced In Situ Tumor Vaccination. |
Q55316979 | Beyond checkpoint inhibition - Immunotherapeutical strategies in combination with radiation. |
Q51551651 | Cancer Cell Death-Inducing Radiotherapy: Impact on Local Tumour Control, Tumour Cell Proliferation and Induction of Systemic Anti-tumour Immunity. |
Q90629204 | Consensus guidelines for the definition, detection and interpretation of immunogenic cell death |
Q87827392 | Exploring the rationale for combining ionizing radiation and immune checkpoint blockade in head and neck cancer |
Q33751085 | Gene and miRNA expression profiles of mouse Lewis lung carcinoma LLC1 cells following single or fractionated dose irradiation. |
Q92741127 | Immune biological rationales for the design of combined radio- and immunotherapies |
Q38641806 | Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors |
Q48193685 | Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases. |
Q39389306 | Intercellular Communication of Tumor Cells and Immune Cells after Exposure to Different Ionizing Radiation Qualities |
Q64943265 | Key mechanisms involved in ionizing radiation-induced systemic effects. A current review. |
Q35909590 | Macrophage polarisation changes within the time between diagnostic biopsy and tumour resection in oral squamous cell carcinomas--an immunohistochemical study |
Q26744490 | Modern Radiotherapy Concepts and the Impact of Radiation on Immune Activation |
Q39365749 | Modulating Both Tumor Cell Death and Innate Immunity Is Essential for Improving Radiation Therapy Effectiveness |
Q60938469 | Potential Role of CXCR4 Targeting in the Context of Radiotherapy and Immunotherapy of Cancer |
Q60956725 | Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing, Dose and Fractionation |
Q26779221 | Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical Applications |
Q38981347 | Rationale and evidence to combine radiation therapy and immunotherapy for cancer treatment |
Q48310789 | Selecting patients for hyperthermia combined with preoperative chemoradiotherapy for locally advanced rectal cancer. |
Q57146748 | Stereotactic Body Radiotherapy: Does It Have a Role in Management of Hepatocellular Carcinoma? |
Q89475171 | Synergistic effect of cisplatin chemotherapy combined with fractionated radiotherapy regimen in HPV-positive and HPV-negative experimental pharyngeal squamous cell carcinoma |
Q37625801 | The Immunoregulatory Potential of Particle Radiation in Cancer Therapy |
Q36069982 | The in vitro immunogenic potential of caspase-3 proficient breast cancer cells with basal low immunogenicity is increased by hypofractionated irradiation |
Q26783291 | The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy |
Search more.